{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:16:08Z","timestamp":1791432968664,"version":"4.3.3"},"reference-count":107,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","award":["23894"],"award-info":[{"award-number":["23894"]}],"id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013465","name":"Association fran\u00e7aise contre les myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002108","name":"Friedreichs Ataxia Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.bbamcr.2024.119809","type":"journal-article","created":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T01:27:11Z","timestamp":1723339631000},"page":"119809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["A multiple animal and cellular models approach to study frataxin deficiency in Friedreich Ataxia"],"prefix":"10.1016","volume":"1871","author":[{"given":"Valentine","family":"Mosbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Puccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamcr.2024.119809_bb0005","first-page":"267","article-title":"Friedreich ataxia: clinical features and new developments, Neurodegener","volume":"12","author":"Keita","year":"2022","journal-title":"Dis. Manag."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0010","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1177\/0883073812448230","article-title":"Clinical features of Friedreich ataxia","volume":"27","author":"Delatycki","year":"2012","journal-title":"J. Child Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.bbamcr.2024.119809_bb0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/jnc.12317","article-title":"Clinical features of Friedreich\u2019s ataxia: classical and atypical phenotypes","volume":"126","author":"Parkinson","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116396","article-title":"The pathogenesis of cardiomyopathy in Friedreich ataxia","volume":"10","author":"Koeppen","year":"2015","journal-title":"PloS One"},{"issue":"Suppl. 1","key":"10.1016\/j.bbamcr.2024.119809_bb0025","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/jnc.12217","article-title":"Cardiomyopathy of Friedreich ataxia","volume":"126","author":"Weidemann","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0030","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/ana.23698","article-title":"Central role and mechanisms of \u03b2-cell dysfunction and death in friedreich ataxia-associated diabetes","volume":"72","author":"Cnop","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0035","first-page":"325","article-title":"The molecular basis of Friedreich ataxia","volume":"15","author":"Pandolfo","year":"2000","journal-title":"Neurologia"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0040","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s40265-023-01874-9","article-title":"Omaveloxolone: first approval","volume":"83","author":"Lee","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0045","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.tips.2023.03.005","article-title":"Omaveloxolone (SkyclarysTM) for patients with Friedreich\u2019s ataxia","volume":"44","author":"Dayalan Naidu","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0050","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","article-title":"Friedreich\u2019s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion","volume":"271","author":"Campuzano","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0055","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ana.24595","article-title":"Compound heterozygous FXN mutations and clinical outcome in friedreich ataxia","volume":"79","author":"Galea","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0060","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U","article-title":"Friedreich\u2019s ataxia: point mutations and clinical presentation of compound heterozygotes","volume":"45","author":"Coss\u00e9e","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0065","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10048-019-00594-1","article-title":"The first biallelic missense mutation in the FXN gene in a consanguineous Turkish family with Charcot-Marie-tooth-like phenotype","volume":"21","author":"Candayan","year":"2020","journal-title":"Neurogenetics"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0070","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/acn3.433","article-title":"Selected missense mutations impair frataxin processing in Friedreich ataxia","volume":"4","author":"Clark","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0075","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s004399900142","article-title":"G130V, a common FRDA point mutation, appears to have arisen from a common founder","volume":"105","author":"Delatycki","year":"1999","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1086\/301680","article-title":"The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure","volume":"62","author":"Bidichandani","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0085","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/hmg\/6.11.1771","article-title":"Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes","volume":"6","author":"Campuzano","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1868-7083-4-2","article-title":"Is Friedreich ataxia an epigenetic disorder?","volume":"4","author":"Kumari","year":"2012","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0095","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1093\/nar\/gkm271","article-title":"Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxia","volume":"35","author":"Greene","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0100","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1074\/jbc.M110.194035","article-title":"Repeat expansion affects both transcription initiation and elongation in friedreich ataxia cells","volume":"286","author":"Kumari","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0105","first-page":"6932","article-title":"Expanded GAA repeats impede transcription elongation through the FXN gene and induce transcriptional silencing that is restricted to the FXN locus","volume":"24","author":"Li","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0110","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/jmg.2008.058594","article-title":"DNA methylation in intron 1 of the frataxin gene is related to GAA repeat length and age of onset in Friedreich ataxia patients","volume":"45","author":"Castaldo","year":"2008","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0115","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ana.22671","article-title":"FXN methylation predicts expression and clinical outcome in Friedreich ataxia","volume":"71","author":"Evans-Galea","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s13361-018-2077-9","article-title":"Ion mobility-mass spectrometry reveals details of formation and structure for GAA\u00b7TCC DNA and RNA triplexes","volume":"30","author":"Li","year":"2019","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0125","doi-asserted-by":"crossref","first-page":"27178","DOI":"10.1074\/jbc.M101852200","article-title":"GGA*TCC-interrupted triplets in long GAA*TTC repeats inhibit the formation of triplex and sticky DNA struc- tures, alleviate transcription inhibition, and reduce genetic instabilities","volume":"276","author":"Sakamoto","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007914","article-title":"Epigenetic silencing in Friedreich ataxia is associated with depletion of CTCF (CCCTC-binding factor) and antisense transcription","volume":"4","author":"De Biase","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0135","first-page":"554","article-title":"The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia","volume":"59","author":"Filla","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0140","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/ana.410410518","article-title":"Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansion","volume":"41","author":"Montermini","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0145","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/jmg.35.9.713","article-title":"Sperm DNA analysis in a Friedreich ataxia premutation carrier suggests both meiotic and mitotic expansion in the FRDA gene","volume":"35","author":"Delatycki","year":"1998","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0150","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1086\/513887","article-title":"Phenotype correlation and intergenerational dynamics of the Friedreich ataxia GAA trinucleotide repeat","volume":"61","author":"Monr\u00f3s","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189990","article-title":"Somatic instability of the expanded GAA repeats in Friedreich\u2019s ataxia","volume":"12","author":"Long","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ana.21052","article-title":"Progressive GAA expansions in dorsal root ganglia of Friedreich\u2019s ataxia patients","volume":"61","author":"De Biase","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0165","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1093\/hmg\/ddn244","article-title":"The in vivo mitochondrial two-step maturation of human frataxin","volume":"17","author":"Schmucker","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0170","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/hmg\/ddm102","article-title":"In vivo maturation of human frataxin","volume":"16","author":"Cond\u00f2","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0175","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/hmg\/9.8.1219","article-title":"Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation","volume":"9","author":"Coss\u00e9e","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0180","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1089\/ars.2011.3921","article-title":"Mitochondrial mayhem: the mitochondrion as a modulator of iron metabolism and its role in disease","volume":"15","author":"Huang","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0185","doi-asserted-by":"crossref","first-page":"25943","DOI":"10.1074\/jbc.C400107200","article-title":"Frataxin-mediated iron delivery to ferrochelatase in the final step of heme biosynthesis","volume":"279","author":"Yoon","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0190","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1039\/B703195E","article-title":"Human frataxin: iron and ferrochelatase binding surface","volume":"Camb","author":"Bencze","year":"2007","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0195","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nchembio.1843","article-title":"Iron-sulfur proteins hiding in plain sight","volume":"11","author":"Rouault","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0200","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nature08301","article-title":"Function and biogenesis of iron-Sulphur proteins","volume":"460","author":"Lill","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0205","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.biochi.2014.01.009","article-title":"Mammalian Fe-S cluster biogenesis and its implication in disease","volume":"100","author":"Beilschmidt","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118863","article-title":"Mechanistic concepts of iron-sulfur protein biogenesis in biology","volume":"1868","author":"Braymer","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0215","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cbpa.2019.11.014","article-title":"Mammalian iron-sulfur cluster biogenesis: recent insights into the roles of frataxin, acyl carrier protein and ATPase-mediated transfer to recipient proteins","volume":"55","author":"Maio","year":"2020","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0220","doi-asserted-by":"crossref","first-page":"19421","DOI":"10.1073\/pnas.1909535116","article-title":"Mechanism of activation of the human cysteine desulfurase complex by frataxin","volume":"116","author":"Patra","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0225","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1038\/ncomms6686","article-title":"Mammalian frataxin directly enhances sulfur transfer of NFS1 persulfide to both ISCU and free thiols","volume":"6","author":"Parent","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016199","article-title":"Mammalian frataxin: an essential function for cellular viability through an interaction with a preformed ISCU\/NFS1\/ISD11 iron-sulfur assembly complex","volume":"6","author":"Schmucker","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0235","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgac142","article-title":"Frataxin controls ketone body metabolism through regulation of OXCT1","volume":"1","author":"Dong","year":"2022","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0240","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41419-023-06320-y","article-title":"Human frataxin, the Friedreich ataxia deficient protein, interacts with mitochondrial respiratory chain","volume":"14","author":"Doni","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0245","article-title":"Role of frataxin protein deficiency and metabolic dysfunction in Friedreich ataxia, an autosomal recessive mitochondrial disease, neuronal","volume":"2","author":"Clark","year":"2018","journal-title":"Signal"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104606","article-title":"Friedreich ataxia- pathogenesis and implications for therapies","volume":"132","author":"Delatycki","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0255","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neurol.2014.03.008","article-title":"Pathophysiogical and therapeutic progress in Friedreich ataxia","volume":"170","author":"Puccio","year":"2014","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0260","first-page":"101","article-title":"Friedreich Ataxia: hypoplasia of spinal cord and dorsal root ganglia","volume":"76","author":"Koeppen","year":"2017","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0265","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-010-0675-0","article-title":"Pathology and pathogenesis of sensory neuropathy in Friedreich\u2019s ataxia","volume":"120","author":"Morral","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0270","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1124\/jpet.118.252759","article-title":"Ferroptosis as a novel therapeutic target for Friedreich\u2019s Ataxia","volume":"369","author":"Cotticelli","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/biom10111489","article-title":"An overview of the Ferroptosis hallmarks in Friedreich\u2019s Ataxia","volume":"10","author":"Turchi","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0280","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1089\/ars.2012.4537","article-title":"Frataxin deficiency leads to defects in expression of antioxidants and Nrf2 expression in dorsal root ganglia of the Friedreich\u2019s ataxia YG8R mouse model","volume":"19","author":"Shan","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20205211","article-title":"Targeting NRF2 for the treatment of Friedreich\u2019s Ataxia: a comparison among drugs","volume":"20","author":"Petrillo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.bbamcr.2024.119809_bb0290","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/jnc.12219","article-title":"Animal and cellular models of Friedreich ataxia","volume":"126","author":"Perdomini","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0295","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/84818","article-title":"Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits","volume":"27","author":"Puccio","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0300","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/hmg\/ddh114","article-title":"Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia","volume":"13","author":"Seznec","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0305","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nm.3510","article-title":"Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich\u2019s ataxia","volume":"20","author":"Perdomini","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0310","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/hmg\/ddy427","article-title":"Correction of half the cardiomyocytes fully rescue Friedreich ataxia mitochondrial cardiomyopathy through cell-autonomous mechanisms","volume":"28","author":"Belbellaa","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0315","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.ymthe.2018.05.006","article-title":"Rapid and complete reversal of sensory Ataxia by gene therapy in a novel model of Friedreich Ataxia","volume":"26","author":"Piguet","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0320","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.045229","article-title":"Mitochondrial damage and senescence phenotype of cells derived from a novel frataxin G127V point mutation mouse model of Friedreich\u2019s ataxia","author":"Fil","year":"2020","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.105996","article-title":"Neuro- behavioral deficits of mice expressing a low level of G127V mutant frataxin","volume":"177","author":"Fil","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0330","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00018-021-04100-5","article-title":"Mice harboring the FXN I151F pathological point mutation present decreased frataxin levels, a Friedreich ataxia-like phenotype, and mitochondrial alterations","volume":"79","author":"Medina-Carbonero","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0335","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.050114","article-title":"Comparative multi-omic analyses of cardiac mitochondrial stress in three mouse models of frataxin deficiency","volume":"16","author":"Sayles","year":"2023","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0340","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1074\/jbc.M112.435263","article-title":"Missense mutations linked to friedreich ataxia have different but synergistic effects on mitochondrial frataxin isoforms","volume":"288","author":"Li","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0345","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/hmg\/ddm038","article-title":"Mitochondrial frataxin interacts with ISD11 of the NFS1\/ISCU complex and multiple mitochondrial chaperones","volume":"16","author":"Shan","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0350","doi-asserted-by":"crossref","first-page":"6478","DOI":"10.1021\/bi200666h","article-title":"Friedreich\u2019s ataxia variants I154F and W155R diminish frataxin-based activation of the iron-sulfur cluster assembly complex","volume":"50","author":"Tsai","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0355","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00018-023-05064-4","article-title":"Mitochondrial impairment, decreased sirtuin activity and protein acetylation in dorsal root ganglia in Friedreich Ataxia models","volume":"81","author":"Sanz-Alc\u00e1zar","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0360","doi-asserted-by":"crossref","unstructured":"V. Chandran, K. Gao, V. Swarup, R. Versano, H. Dong, M.C. Jordan, D.H. Geschwind, Inducible and reversible phenotypes in a novel mouse model of Friedreich's Ataxia, eLife 6 (n.d.) e30054. doi:https:\/\/doi.org\/10.7554\/eLife.30054.","DOI":"10.7554\/eLife.30054"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.819569","article-title":"Cerebellar pathology in an inducible mouse model of Friedreich Ataxia","volume":"16","author":"Mercado-Ay\u00f3n","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0370","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0014-5793(02)02251-2","article-title":"Frataxin knockin mouse","volume":"512","author":"Miranda","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0375","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbr.2016.08.053","article-title":"Neurobehavioral deficits in the KIKO mouse model of Friedreich\u2019s ataxia","volume":"316","author":"McMackin","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0380","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1038\/s41598-020-62952-6","article-title":"Long-term voluntary running prevents the onset of symptomatic Friedreich\u2019s ataxia in mice","volume":"10","author":"Zhao","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0385","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1242\/dmm.030502","article-title":"Early cerebellar deficits in mitochondrial biogenesis and respiratory chain complexes in the KIKO mouse model of Friedreich ataxia","volume":"10","author":"Lin","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0390","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1242\/dmm.030049","article-title":"Early VGLUT1-specific parallel fiber synaptic deficits and dysregulated cerebellar circuit in the KIKO mouse model of Friedreich ataxia","volume":"10","author":"Lin","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0395","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ygeno.2006.06.015","article-title":"GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology","volume":"88","author":"Al-Mahdawi","year":"2006","journal-title":"Genomics"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107416","article-title":"Cellular, Molecular and functional characterisation of YAC transgenic mouse models of Friedreich Ataxia","volume":"9","author":"Anjomani Virmouni","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0405","unstructured":"S.A. Virmouni, V. Ezzatizadeh, C. Sandi, M. Sandi, S. Al-Mahdawi, Y. Chutake, M.A. Pook, A novel GAA-repeat-expansion-based mouse model of Friedreich's ataxia, (2015) 11."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0410","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.930422","article-title":"A new FRDA mouse model [Fxn null:YG8s(GAA) > 800] with more than 800 GAA repeats","volume":"17","author":"Kalef-Ezra","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.114107","article-title":"A promising mouse model for Friedreich Ataxia progressing like human patients","volume":"436","author":"G\u00e9rard","year":"2023","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0420","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0425","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.stem.2010.09.014","article-title":"Friedreich\u2019s ataxia induced pluripotent stem cells model intergenerational GAA\u00b7TTC triplet repeat instability","volume":"7","author":"Ku","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0430","first-page":"608","article-title":"Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich\u2019s ataxia","volume":"6","author":"Hick","year":"2013","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0435","article-title":"Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells","volume":"466","author":"Lee","year":"2014","journal-title":"Pflugers Archiv\u00a0: European Journal of Physiology"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0440","first-page":"81","article-title":"Progress in understanding Friedreich\u2019s ataxia using human induced pluripotent stem cells, expert Opin orphan","volume":"7","author":"Schreiber","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0445","doi-asserted-by":"crossref","first-page":"7752","DOI":"10.1038\/s41598-020-64831-6","article-title":"Primary proprioceptive neurons from human induced pluripotent stem cells: a cell model for afferent ataxias","volume":"10","author":"Dionisi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0450","article-title":"Proprioceptors-enriched neuronal cultures from induced pluripotent stem cells from Friedreich ataxia patients show altered transcriptomic and proteomic profiles, abnormal neurite extension, and impaired electrophysiological properties","volume":"5","author":"Dionisi","year":"2023","journal-title":"Brain Commun"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0455","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1038\/s41467-020-17954-3","article-title":"Frataxin gene editing rescues Friedreich\u2019s ataxia pathology in dorsal root ganglia organoid-derived sensory neurons","volume":"11","author":"Mazzara","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0460","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.18632\/aging.101247","article-title":"Friedreich\u2019s ataxia induced pluripotent stem cell-derived cardiomyocytes display electrophysiological abnormalities and calcium handling deficiency","volume":"9","author":"Crombie","year":"2017","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2019.101529","article-title":"Excision of the expanded GAA repeats corrects cardiomyopathy phenotypes of iPSC-derived Friedreich\u2019s ataxia cardiomyocytes","volume":"40","author":"Li","year":"2019","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0470","article-title":"Pharmacological treatments for Friedreich ataxia","volume":"2016","author":"Kearney","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0475","first-page":"961","article-title":"Translating HDAC inhibitors in Friedreich\u2019s ataxia, expert Opin orphan","volume":"4","author":"Soragni","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0480","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.nbd.2011.02.016","article-title":"Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model","volume":"42","author":"Sandi","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001958","article-title":"HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model","volume":"3","author":"Rai","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008825","article-title":"Two new pimelic diphenylamide HDAC inhibitors induce sustained frataxin upregulation in cells from Friedreich\u2019s ataxia patients and in a mouse model","volume":"5","author":"Rai","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0495","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1093\/hmg\/ddt115","article-title":"Heterochromatinization induced by GAA-repeat hyper- expansion in Friedreich\u2019s ataxia can be reduced upon HDAC inhibition by vitamin B3","volume":"22","author":"Chan","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0500","first-page":"4847","article-title":"Friedreich ataxia-induced pluripotent stem cell-derived neurons show a cellular phenotype that is corrected by a benzamide HDAC inhibitor","volume":"25","author":"Codazzi","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0505","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.836476","article-title":"Selected histone deacetylase inhibitors reverse the Frataxin transcriptional defect in a novel Friedreich\u2019s Ataxia induced Pluri- potent stem cell-derived neuronal reporter system","volume":"16","author":"Schreiber","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0510","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/acn3.51971","article-title":"Safety, pharmacokinetics, and pharmacodynamics of nomlabofusp (CTI-1601) in Friedreich\u2019s ataxia","volume":"11","author":"Clayton","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0515","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/hmg\/ddr554","article-title":"A TAT-frataxin fusion protein increases lifespan and cardiac function in a conditional Friedreich\u2019s ataxia mouse model","volume":"21","author":"Vyas","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"Suppl. 1","key":"10.1016\/j.bbamcr.2024.119809_bb0520","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00415-009-1002-3","article-title":"Friedreich ataxia: the clinical picture","volume":"256","author":"Pandolfo","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0525","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1586\/14737175.2014.939173","article-title":"Therapeutic approaches for the treatment of Friedreich\u2019s ataxia","volume":"14","author":"Strawser","year":"2014","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bbamcr.2024.119809_bb0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004253","article-title":"Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia","volume":"4","author":"Paupe","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.bbamcr.2024.119809_bb0535","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fncel.2018.00188","article-title":"Novel Nrf2-inducer prevents mitochondrial defects and oxidative stress in Friedreich\u2019s Ataxia models","volume":"12","author":"Abeti","year":"2018","journal-title":"Front. Cell. Neurosci."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488924001526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488924001526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:31:31Z","timestamp":1759368691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488924001526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":107,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0167488924001526"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2024.119809","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multiple animal and cellular models approach to study frataxin deficiency in Friedreich Ataxia","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2024.119809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119809"}}